4//SEC Filing
McKee Kelly T. Jr. 4
Accession 0001437749-25-019630
CIK 0000832489other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 9:41 AM ET
Size
5.8 KB
Accession
0001437749-25-019630
Insider Transaction Report
Form 4
McKee Kelly T. Jr.
Chief Medical Officer
Transactions
- Award
Stock Option
2025-06-05+70,000→ 70,000 totalExercise: $2.48Exp: 2035-01-02→ Common Stock (70,000 underlying)
Footnotes (2)
- [F1]Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.
- [F2]This stock option was granted on January 2, 2025, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of the GeoVax Labs, Inc. 2025 Stock Incentive Plan. Such approval occurred on June 5, 2025, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance.
Documents
Issuer
GeoVax Labs, Inc.
CIK 0000832489
Entity typeother
Related Parties
1- filerCIK 0001903889
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 9:41 AM ET
- Size
- 5.8 KB